Seres Therapeutics logo

Seres Therapeutics Share Price Today

(NASDAQ: MCRB)

Seres Therapeutics share price is $10.08 & ₹861.41 as on 26 Apr 2025, 2.30 'hrs' IST

$10.08

1

(11.01%)

Market is closed - opens 7 PM, 28 Apr 2025

View live Seres Therapeutics share price in Dollar and Rupees. Guide to invest in Seres Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Seres Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Seres Therapeutics share price movements

  • Today's Low: $9.05
    Today's High: $10.25

    Day's Volatility :11.76%

  • 52 Weeks Low: $7.18
    52 Weeks High: $30.60

    52 Weeks Volatility :76.54%

Seres Therapeutics (MCRB) Returns

PeriodSeres Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-39.76%
-6.4%
0.0%
6 Months
-27.57%
-7.1%
0.0%
1 Year
-44.22%
-1.4%
0.0%
3 Years
-89.59%
4.7%
-6.1%

Seres Therapeutics (MCRB) Key Statistics

in dollars & INR

Previous Close
$9.08
Open
$9.0
Today's High
$10.25
Today's Low
$9.045
Market Capitalization
$79.2M
Today's Volume
$272.0K
52 Week High
$30.6
52 Week Low
$7.179
Revenue TTM
$126.3M
EBITDA
$-115.8M
Earnings Per Share (EPS)
$-16.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1556.28%

How to invest in Seres Therapeutics Stock (MCRB) from India?

It is very easy for Indian residents to invest directly in Seres Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Seres Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Seres Therapeutics or MCRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Seres Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Seres Therapeutics shares which would translate to 0.085 fractional shares of Seres Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Seres Therapeutics, in just a few clicks!

Returns in Seres Therapeutics (MCRB) for Indian investors in Rupees

The Seres Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Seres Therapeutics investment value today

Current value as on today

₹58,004

Returns

₹41,996

(-42%)

Returns from Seres Therapeutics Stock

₹44,554 (-44.55%)

Dollar Returns

₹2,558 (+2.56%)

Indian investors sentiment towards Seres Therapeutics (MCRB)

-64%

Period: Mar 27, 2025 to Apr 26, 2025. Change in 30 Days versus previous period

Search interest for Seres Therapeutics Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Seres Therapeutics

  • Flagship Ventures Management, Inc.

    13.26%

  • FMR Inc

    12.51%

  • Vanguard Group Inc

    3.37%

  • Morgan Stanley - Brokerage Accounts

    1.15%

  • Millennium Management LLC

    1.04%

  • BlackRock Inc

    1.01%

Analyst Recommendation on Seres Therapeutics

Rating
Trend

Buy

    76%Buy

    15%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Seres Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Seres Therapeutics Stock (MCRB)

What analysts predicted

Upside of 710.19%

Target:

$81.67

Current:

$10.08

Insights on Seres Therapeutics Stock (Ticker Symbol: MCRB)

  • Price Movement

    In the last 7 days, MCRB stock has moved up by 37.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 126.47M → 64.0K (in $), with an average decrease of 89.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 88.77M → -15.63M (in $), with an average decrease of 117.6% per quarter
  • MCRB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 114.1%
  • MCRB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 62.5% return, outperforming this stock by 152.0%
  • Price to Sales

    ForMCRB every $1 of sales, investors are willing to pay $11.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.3 for every $1 of sales.

Seres Therapeutics Technicals Summary

Sell

Neutral

Buy

Seres Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Seres Therapeutics (MCRB) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Seres Therapeutics Inc logo
-32.87%
-27.57%
-44.22%
-89.59%
-86.59%
Regeneron Pharmaceuticals, Inc. logo
-5.48%
-35.12%
-32.5%
-10.82%
13.97%
Beone Medicines Ltd logo
-8.49%
12.64%
56.32%
54.42%
50.0%
Vertex Pharmaceuticals Incorporated logo
0.24%
3.67%
24.65%
83.83%
92.19%
Alnylam Pharmaceuticals, Inc. logo
-6.24%
-12.27%
70.81%
75.82%
83.05%

About Seres Therapeutics

Seres Therapeutics, Inc., a clinical-stage company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. The company develops a novel class of biological drugs that are designed to treat by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The company's product candidate is VOWST, the first FDA-approved orally administered microbiome therapeutic. Its product pipeline also includes SER-155, an investigational, oral, live biotherapeutic designed to decolonize gastrointestinal, or GI, pathogens, improve epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, or BSIs, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation, or allo-HSCT. In addition, the company engages in the development of SER-287 which is in Phase 2b and SER-301 that is in Phase 1b to treat ulcerative colitis. Further, it develops SER-147, an investigational live biotherapeutic designed to prevent bacterial bloodstream and spontaneous bacterial peritonitis, or SBP, infections in patients with metabolic disease, including clinical liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Organization
Seres Therapeutics
Employees
103
CEO
Mr. Eric D. Shaff M.B.A.
Industry
Health Technology

Management People of Seres Therapeutics

NameTitle
Mr. Eric D. Shaff M.B.A.
President, CEO & Director
Mr. Thomas J. DesRosier Esq., J.D.
Chief Legal Officer, Executive VP & Secretary
Ms. Marella Thorell CPA
Executive VP & CFO
Dr. Matthew R. Henn Ph.D.
Executive VP & Chief Scientific Officer
Dr. Teresa L. Young Ph.D., R.Ph.
Executive VP and Chief Commercial & Strategy Officer
Mr. Chris McChalicher
Senior VP of Manufacturing, Quality, and Process Development
Dr. Dennis M. Walling M.D.
Senior VP of Clinical Development & Head of Clinical Research
Ms. Ann Kurowski
Senior Vice President of Regulatory Affairs
Ms. Kelly Brady
Senior Vice President of Clinical Development
Ms. Caroline Holda
Assistant General Counsel

Important FAQs about investing in MCRB Stock from India :

What is Seres Therapeutics share price today?

Seres Therapeutics share price today stands at $10.08, Open: $9.00 ; Previous Close: $9.08 ; High: $10.25 ; Low: $9.05 ; 52 Week High: $30.60 ; 52 Week Low: $7.18.

The stock opens at $9.00, after a previous close of $9.08. The stock reached a daily high of $10.25 and a low of $9.05, with a 52-week high of $30.60 and a 52-week low of $7.18.

Can Indians buy Seres Therapeutics shares?

Yes, Indians can invest in the Seres Therapeutics (MCRB) from India.

With INDmoney, you can buy Seres Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Seres Therapeutics at zero transaction cost.

How can I buy Seres Therapeutics shares from India?

It is very easy to buy Seres Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Seres Therapeutics (MCRB) be purchased?

Yes, you can buy fractional shares of Seres Therapeutics with INDmoney app.

What are the documents required to start investing in Seres Therapeutics stocks?

To start investing in Seres Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Seres Therapeutics Stock (MCRB)?

Today’s highest price of Seres Therapeutics (MCRB) is $10.25.

Today’s lowest price of Seres Therapeutics (MCRB) is $9.05.

What is today's market capitalisation of Seres Therapeutics?

Today's market capitalisation of Seres Therapeutics MCRB is 79.2M

What is the 52 Week High and Low Range of Seres Therapeutics Stock (MCRB)?

  • 52 Week High

    $30.60

  • 52 Week Low

    $7.18

What are the historical returns of Seres Therapeutics (MCRB)?

  • 1 Month Returns

    -32.87%

  • 3 Months Returns

    -27.57%

  • 1 Year Returns

    -44.22%

  • 5 Years Returns

    -86.59%

Who is the Chief Executive Officer (CEO) of Seres Therapeutics ?

Mr. Eric D. Shaff M.B.A. is the current Chief Executive Officer (CEO) of Seres Therapeutics.